Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, March 14, 2011

(PreOvar test) Mira Dx™ Dismisses Flawed Study as “Puzzling,” and “Comparing Apples and Oranges” | Business Wire (refers to sgo presentation/KRAS mutation variant....)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.